Skip to main content
UC Davis Stem Cell Program

UC Davis Stem Cell Program

News releases

June 2015arrow

Knoepfler awarded childhood cancer research grant

June 25, 2015

UC Davis stem cell scientist Paul Knoepfler has been awarded $250,000 for glioma research from an organization begun 15 years ago by a 5-year-old girl with a deadly form of childhood cancer.

April 2015arrow

Prenatal stem cell treatment improves mobility issues caused by spina bifida

April 24, 2015

The lower-limb paralysis associated with spina bifida may be effectively treated before birth by combining a unique stem cell therapy with surgery, new research from UC Davis Health System has found.

March 2015arrow

UC Davis receives stem cell grants for novel spina bifida and diabetic wound treatments

March 26, 2015

The state stem cell agency, California Institute for Regenerative Medicine (CIRM), today awarded a pair of grants totaling more than $7 million to UC Davis School of Medicine researchers who are working to develop stem cell therapies for spina bifida and chronic diabetic wounds.

December 2014arrow

New technique for bioengineering stem cells shows promise in HIV resistance

December 22, 2014

Using modified human stem cells, a team of UC Davis scientists has developed an improved gene therapy strategy that in animal models shows promise as a functional cure for the human immunodeficiency virus (HIV) that causes AIDS.  The achievement, which involves an improved technique to purify populations of HIV-resistant stem cells, opens the door for human clinical trials that were recently approved by the U.S. Food and Drug Administration.

October 2014arrow

Anti-cancer drug found effective against common stem cell transplant complication

October 24, 2014

Researchers at UC Davis have found that the drug bortezomib effectively treats chronic graft-versus-host disease (GVHD), a common and debilitating side effect from allogeneic hematopoietic stem cell transplants.

September 2014arrow

UC Davis-developed target leukemia treatment shows promise

September 11, 2014

Noriko Satake, UC Davis pediatric oncologist and researcher, has demonstrated in laboratory studies that a new, targeted treatment for leukemia is effective.